# FDA Warning Letter: ALI Pharmaceutical Manufacturing, LLC
> 2023-10-31 · Division of Pharmaceutical Quality Operations III · `437baddccade8634`
## Letter
- **Company:** ALI Pharmaceutical Manufacturing, LLC
- **Posted Date:** 2023-10-31
- **Letter Issue Date:** 2023-03-30
- **Issuing Office:** Division of Pharmaceutical Quality Operations III
## Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*